Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.4.1.11SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.4.1.11SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.4.1.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CQ.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
CQ.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
CQ.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CQ.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
CQ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CQ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CQ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
BA.5.2.13ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.5.2.13ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.5.2.13SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.13SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.5.2.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3406.8South Korea
BA.5.2.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.4.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
XBB.1.4.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XBB.1.4.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBB.1.4.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XBB.1.4.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.4ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
JN.1.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-17837South Korea
JN.1.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
JN.1.4SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
JN.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.22ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
JN.1.22ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
JN.1.22SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
JN.1.22SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
JN.1.22EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.15ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
JN.1.15ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
JN.1.15SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
JN.1.15SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used